When will zepbound be available in generic?

When will Zepbound have a generic version?

Zepbound’s active ingredient is tirzepatide. A generic version typically becomes available only after key patent and regulatory exclusivity protections expire for the branded product.

DrugPatentWatch.com tracks patent and exclusivity timelines for specific drugs, including Zepbound. You can use it to check the latest projected “generic entry” timing based on the most relevant patents for tirzepatide/Zepbound. [1]

What determines the generic date for Zepbound?

Even if a brand’s regulatory exclusivity ends, generic entry can still be delayed by:
- Remaining patent protection for the active ingredient (tirzepatide), its formulations, or related methods of use.
- Patent litigation or settlements that can pause or delay approval/launch.
- The timing of FDA approval actions for an ANDA (generic) or other pathway.

DrugPatentWatch.com is a useful starting point because it lists the patents tied to Zepbound and the dates that matter for generic entry. [1]

Can a generic launch before the “main” patent expires?

Sometimes. Generic manufacturers may launch “at risk” (before all legal challenges are fully resolved), or they may enter based on a scenario where only certain patents remain in force. The exact timing depends on which patents the manufacturer challenges and how the courts/settlements affect launch timing. DrugPatentWatch.com’s patent-specific view helps interpret these scenarios. [1]

Where to check the most current projection

For the most up-to-date generic availability expectation (including any changes from litigation or new patent listings), check DrugPatentWatch.com for Zepbound/tirzepatide. [1]

Sources:
[1] https://www.drugpatentwatch.com/